Cargando…
Current Status of Monoclonal Antibodies-Based Therapies in Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials
Background Multiple patients with prostate cancer become resistant to castration therapies, which is termed castration-resistant prostate cancer (CRPC). Purpose The purpose of this review is to assess the status of efficacy (≥50% decline in prostate-specific antigen (PSA), progression-free survival...
Autores principales: | Tarrar, Talha Azam, Anwar, Muhammad Yasir, Ali, Muhammad Ashar, Saeed, Memoona, Rehman, Sana, Bajwa, Shammas F, Ayub, Tooba, Javid, Haleema, Ali, Rimsha, Irshad, Alaa, Aiman, Wajeeha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989703/ https://www.ncbi.nlm.nih.gov/pubmed/35411277 http://dx.doi.org/10.7759/cureus.22942 |
Ejemplares similares
-
Diethylstilbestrol in the Treatment of Castration-resistant Prostate Cancer: A Lower-middle-income Country Experience
por: Ali, Azfar, et al.
Publicado: (2019) -
Comparison of Outcomes Between Radical Radiotherapy and Radical Cystectomy in Muscle Invasive Bladder Cancer in a Cancer Specialized Unit of a Developing Country
por: Fiaz, Shaukat, et al.
Publicado: (2020) -
Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials
por: Ali, Muhammad Ashar, et al.
Publicado: (2020) -
Oncological Outcomes of Non-Urothelial Bladder Cancers in a Specialized Cancer Hospital of a Developing Country
por: Adnan, Siddique, et al.
Publicado: (2020) -
Outcomes of Uretero-ileal Anastomosis in Bladder Cancer Cystectomies: Bricker vs. Wallace 1
por: Adnan, Siddique, et al.
Publicado: (2022)